Basic Information
| RNALocate ID: | RLID:11003899 |
| RNA Symbol: | hsa-miR-340-5p |
| Localization: | Exosome |
RNA Information
| RNA Name: | hsa-miR-340-5p |
| RNA ID: | miRBase:MIMAT0004692 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 23663360 |
| Tissue/Cell Line: | Plasma |
| Method: | Next-generation RNA sequencing |
| Description: | Because the abundance of most miRNAs is low in the exosomes, we defined detectable miRNAs as those that had at least one sequence per million mappable miRNA reads. Accordingly, we detected a total of 593 known miRNAs in the 14 libraries. In each individual library, the number of detectable known miRNAs varied from 380 to 474 with an average of 419 [see Additional file 2]. Data are collected from Additional file 2: Read counts of the miRNAs detected in the 14 libraries (normalized to read number per million mappable miRNA seqeuences). |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01002631 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
| RLID:11003895 | Exosome | Serum | 29143228 |
| RLID:11003896 | Exosome | Serum | 18589210 |
| RLID:11003897 | Exosome | Primary dendritic cells|T cell line (J77) | 21505438 |
| RLID:11003898 | Exosome | Brain tissue | 23382797 |
| RLID:11003900 | Exosome | Human mast cell line (HMC-1) | 24009880 |
| RLID:11003901 | Exosome | B cell lymphoma cell lines|EBV-transformed lymphoblastoid B cells | 25242326 |
| RLID:11003902 | Extracellular vesicle | HEK-293T cells | 22849433 |
| RLID-D:11000198 | Exosome | Blood|Breast milk|Endothelial cells|Mast cells|Seminal fluid|Tongue tissue | |
| RLID-D:11000664 | Microvesicle | Blood|Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-340-5p | Multiple sclerosis chronic progressive | MNDR-E-MI-41928 |
| MNDR | hsa-miR-340-5p | Rheumatic heart diseases | MNDR-E-MI-41929 |
| MNDR | hsa-miR-340-5p | Oral squamous cell carcinoma | MNDR-E-MI-41930 |
| MNDR | hsa-miR-340-5p | Medulloblastoma | MNDR-E-MI-41931 |
| MNDR | hsa-miR-340-5p | Lymphoma | MNDR-E-MI-41932 |
| MNDR | hsa-miR-340-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-41933 |
| MNDR | hsa-miR-340-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-41934 |
| MNDR | hsa-miR-340-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-41935 |
| MNDR | hsa-miR-340-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-41936 |
| MNDR | hsa-miR-340-5p | Her2-receptor positive breast cancer | MNDR-E-MI-41937 |
| MNDR | hsa-miR-340-5p | Triple negative breast cancer | MNDR-E-MI-41938 |
| MNDR | hsa-miR-340-5p | Breast cancer luminal | MNDR-E-MI-41939 |
| MNDR | hsa-miR-340-5p | Dermatomyositis | MNDR-E-MI-41940 |
| MNDR | hsa-miR-340-5p | Prostate cancer | MNDR-E-MI-41941 |
| MNDR | hsa-miR-340-5p | Gastric cancer | MNDR-E-MI-41942 |
| MNDR | hsa-miR-340-5p | Alzheimer disease | MNDR-E-MI-41943 |
| MNDR | hsa-miR-340-5p | Dysautonomia familial | MNDR-E-MI-41944 |
| MNDR | hsa-miR-340-5p | Huntington disease | MNDR-E-MI-41945 |
| MNDR | hsa-miR-340-5p | Cardiovascular disease | MNDR-E-MI-41946 |
| MNDR | hsa-miR-340-5p | Lung cancer | MNDR-E-MI-41947 |
| MNDR | hsa-miR-340-5p | Parkinson disease | MNDR-E-MI-41948 |
| MNDR | hsa-miR-340-5p | Basal-like breast cancer | MNDR-E-MI-41949 |
| MNDR | hsa-miR-340-5p | Thyroid cancer | MNDR-E-MI-41950 |
| MNDR | hsa-miR-340-5p | Pituitary neoplasms | MNDR-E-MI-41951 |
| MNDR | hsa-miR-340-5p | Pancreatic cancer | MNDR-E-MI-41952 |
| MNDR | hsa-miR-340-5p | Melanoma | MNDR-E-MI-41953 |
| MNDR | hsa-miR-340-5p | Colon cancer | MNDR-E-MI-41954 |
| MNDR | hsa-miR-340-5p | Colon adenocarcinoma | MNDR-E-MI-41955 |
| MNDR | hsa-miR-340-5p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-41956 |
| MNDR | hsa-miR-340-5p | Ovarian cancer | MNDR-E-MI-41957 |
| MNDR | hsa-miR-340-5p | Acromegaly | MNDR-E-MI-41958 |
| MNDR | hsa-miR-340-5p | Prostate adenocarcinoma | MNDR-E-MI-41959 |
| MNDR | hsa-miR-340-5p | Kidney cancer | MNDR-E-MI-41960 |
| MNDR | hsa-miR-340-5p | Carcinoma ductal breast | MNDR-E-MI-41961 |
| MNDR | hsa-miR-340-5p | Glioblastoma | MNDR-E-MI-41962 |
| MNDR | hsa-miR-340-5p | Glioma | MNDR-E-MI-41963 |
| MNDR | hsa-miR-340-5p | Neurilemmoma | MNDR-E-MI-41964 |
| MNDR | hsa-miR-340-5p | Central nervous system lymphoma | MNDR-E-MI-41965 |
| MNDR | hsa-miR-340-5p | Amyotrophic lateral sclerosis | MNDR-E-MI-41966 |
| MNDR | hsa-miR-340-5p | Epilepsy temporal lobe | MNDR-E-MI-41967 |
| MNDR | hsa-miR-340-5p | Coronary artery disease | MNDR-E-MI-41968 |
| MNDR | hsa-miR-340-5p | Inclusion body myositis | MNDR-E-MI-41969 |
| MNDR | hsa-miR-340-5p | Breast carcinoma | MNDR-E-MI-41970 |
| MNDR | hsa-miR-340-5p | Uterine cancer | MNDR-E-MI-41971 |
| MNDR | hsa-miR-340-5p | Pituitary adenoma | MNDR-E-MI-41972 |
| MNDR | hsa-miR-340-5p | Lung squamous cell carcinoma | MNDR-E-MI-41973 |
| MNDR | hsa-miR-340-5p | Lung adenocarcinoma | MNDR-E-MI-41974 |
| MNDR | hsa-miR-340-5p | Adrenocortical carcinoma | MNDR-E-MI-41975 |
| MNDR | hsa-miR-340-5p | Bladder urothelial carcinoma | MNDR-E-MI-41976 |
| MNDR | hsa-miR-340-5p | Carcinoma renal cell | MNDR-E-MI-41977 |
| MNDR | hsa-miR-340-5p | Kidney renal papillary cell carcinoma | MNDR-E-MI-41978 |
| MNDR | hsa-miR-340-5p | Renal clear cell carcinoma | MNDR-E-MI-41979 |
| MNDR | hsa-miR-340-5p | Cholangiocarcinoma | MNDR-E-MI-41980 |
| MNDR | hsa-miR-340-5p | Esophageal cancer | MNDR-E-MI-41981 |
| MNDR | hsa-miR-340-5p | Liver cirrhosis | MNDR-E-MI-41982 |
| MNDR | hsa-miR-340-5p | Lung small cell carcinoma | MNDR-E-MI-41983 |
| MNDR | hsa-miR-340-5p | Synovial sarcoma | MNDR-E-MI-41984 |
| MNDR | hsa-miR-340-5p | Head and neck squamous cell carcinoma | MNDR-E-MI-41985 |
| MNDR | hsa-miR-340-5p | Growth hormone-secreting pituitary adenoma | MNDR-E-MI-41986 |
| MNDR | hsa-miR-340-5p | Breast invasive carcinoma | MNDR-E-MI-41987 |
| MNDR | hsa-miR-340-5p | Early hepatocellular carcinoma | MNDR-E-MI-41988 |
| MNDR | hsa-miR-340-5p | Embryonal cancer | MNDR-E-MI-41989 |
| MNDR | hsa-miR-340-5p | Lymphoblastoid | MNDR-E-MI-41990 |
| MNDR | hsa-miR-340-5p | Rheumatoid arthritis | MNDR-E-MI-41991 |
| MNDR | hsa-miR-340-5p | Retinoblastoma | MNDR-E-MI-41992 |
| MNDR | hsa-miR-340-5p | Barrett's adenocarcinoma | MNDR-E-MI-41993 |
| MNDR | hsa-miR-340-5p | Hodgkin lymphoma | MNDR-E-MI-41994 |
| MNDR | hsa-miR-340-5p | Burkitt lymphoma | MNDR-E-MI-41995 |
| MNDR | hsa-miR-340-5p | Tonsil cancer | MNDR-E-MI-41996 |
| MNDR | hsa-miR-340-5p | Acute myeloid leukemia | MNDR-E-MI-41997 |
| MNDR | hsa-miR-340-5p | Colorectal cancer | MNDR-E-MI-41998 |
| MNDR | hsa-miR-340-5p | Nasopharynx carcinoma | MNDR-E-MI-41999 |
| MNDR | hsa-miR-340-5p | Multiple myeloma | MNDR-E-MI-42000 |
| MNDR | hsa-miR-340-5p | Nasopharyngeal cancer | MNDR-E-MI-42001 |
| MNDR | hsa-miR-340-5p | Stroke lacunar | MNDR-E-MI-42002 |
| MNDR | hsa-miR-340-5p | Barrett's carcinogenesis | MNDR-E-MI-42003 |
| MNDR | hsa-miR-340-5p | Breast cancer her3+ negative | MNDR-E-MI-42004 |
| MNDR | hsa-miR-340-5p | Low grade dysplastic nodule | MNDR-E-MI-42005 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | BCL11A | Homo sapiens | RR00218496 |
TOP